Clinical evaluation of combined treatment of stage III (B) Hodgkin's disease
Kanaev, S.V.; Golovanov, S.G.; Girshovich, M.M.; Gershanovich, M.L.
Voprosy Onkologii 52(5): 525-530
2006
ISSN/ISBN: 0507-3758 PMID: 17168360 Document Number: 600234
N.N.Petrov Research Institute of Oncology, St.PetersburgPatients with stage III Hodgkin's disease (110) received 2-3 courses of combination chemotherapy followed by total or subtotal irradiation, or exposure of primarily involved lymph nodes. The study did not include patients with persistent symptoms of intoxication. Overall 5- and 10-year survival rates were 78 and 68%, recurrence-free- 75 and 74% respectively.